Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

NCT01946555 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.

NCT NCT01946555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01946555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
Lead sponsor
Mario Negri Institute for Pharmacological Research
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
December 31, 2015
Enrollment
150 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breakthrough cancer pain, cancer pain, neuropathic pain, tumor